TipRanks
Go Ultimate55% OFF

Kanoria Chemicals & Industries Ltd (KANORICHEM) AI Stock Analysis

IN:KANORICHEM

Kanoria Chemicals & Industries Ltd

(NSE:KANORICHEM)

Select Model
Rating:56Neutral
Price Target:INR 193.00â–²(14.27% Upside)
Action:reiterated
Date:09/11/26

Weak financial performance from revenue declines, losses and cash flow challenges is the dominant factor capping the score, partially offset by strong technical momentum from price action above key moving averages.

Positive Factors
Lower LeverageMeaningful debt reduction improves financial flexibility and can lower the burden of future interest and refinancing needs. With substantial equity relative to assets, the company is better positioned to withstand operating volatility and direct resources toward stabilizing its chemicals business.
Negative Factors
Sharp Revenue DeclineThe sharp 2026 revenue contraction signals pressure on demand, pricing, or both within the company’s industrial chemicals markets. Lower sales reduce operating leverage and make it harder to sustain margins, absorb fixed costs, or build a dependable earnings base.

Kanoria Chemicals & Industries Ltd (KANORICHEM) vs. iShares MSCI India ETF (INDA)

-50%0%50%100%150%200%IN:KANORICHEM+119.07%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 7.56B
Dividend Yield
―
Average Volume (3M)
7,761
Price to Earnings (P/E)
12.8
Beta (1Y)
1.27
Revenue Growth
-22.78%
EPS Growth
―
Country
India
Employees
385
Sector
General
Sector Strength
55
Industry
Chemicals

Kanoria Chemicals & Industries Ltd Business Overview & Revenue Model

Company Description

Kanoria Chemicals & Industries Limited (KCIL), an Indian enterprise established in 1960 and based in New Delhi, specializes in the production and distribution of chemical intermediates. Operating primarily through its Alco Chemicals and Solar Power d...

How the Company Makes Money

Kanoria Chemicals & Industries Ltd primarily makes money by manufacturing and selling industrial chemicals. The company’s key revenue stream is the sale of chlor-alkali products—most notably caustic soda—along with co-products such as chlorine and al...

Kanoria Chemicals & Industries Ltd Financial Statement Overview

Summary

Weak income statement marked by revenue volatility and net losses, moderate balance sheet with rising debt, and declining cash flows with negative free cash flow result in subdued financial performance.

Income Statement

35Negative

Balance Sheet

55Neutral

Cash Flow

40Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue12.40B9.81B15.37B14.75B15.78B13.69B
Gross Profit2.21B1.81B4.71B4.67B4.62B3.86B
EBITDA1.18B713.40M106.12M642.63M826.89M955.19M
Net Income573.10M231.20M-836.00M-383.96M-87.70M68.26M
Balance Sheet
Total Assets011.17B14.98B14.90B14.81B14.03B
Cash, Cash Equivalents and Short-Term Investments104.61M180.20M109.60M141.07M308.20M314.68M
Total Debt02.91B5.95B5.09B5.10B4.75B
Total Liabilities-5.73B5.44B9.88B8.73B8.74B8.01B
Stockholders Equity5.73B5.73B5.21B6.01B6.05B5.98B
Cash Flow
Free Cash Flow-249.90M-118.40M-800.10M-432.20M-317.60M402.19M
Operating Cash Flow77.10M470.70M202.80M375.70M257.20M830.76M
Investing Cash Flow-242.20M-157.40M-648.70M-503.50M-249.80M-431.08M
Financing Cash Flow571.80M-250.10M414.60M51.40M34.49M-530.48M

Kanoria Chemicals & Industries Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price168.90

Price Trends

50DMA173.65Negative
100DMA154.40Positive
200DMA115.59Positive

Market Momentum

MACD-0.76Positive
RSI44.44Neutral
STOCH41.15Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KANORICHEM, the sentiment is Negative. The current price of 168.90 is below the 20-day moving average (MA) of 177.23, below the 50-day MA of 173.65, and above the 200-day MA of 115.59, indicating a neutral trend. The MACD of -0.76 indicates Positive momentum. The RSI at 44.44 is Neutral, neither overbought nor oversold. The STOCH value of 41.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KANORICHEM.

Kanoria Chemicals & Industries Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:KANORICHEM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:AMNPLSTIN:AMNPLST66NeutralINR 7.87B20.29―0.35%-12.40%-3.04%
IN:DEEPAKNTRIN:DEEPAKNTR65NeutralINR 207.25B19.51―0.49%25.13%99.89%
IN:VALIANTORGIN:VALIANTORG64NeutralINR 11.77B21.82――1.41%946.41%
IN:INDOAMININ:INDOAMIN61NeutralINR 8.68B10.73―0.42%13.23%22.22%
IN:KANORICHEMIN:KANORICHEM56NeutralINR 7.38B12.76――-22.78%―
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DIAMINESQIN:DIAMINESQ43NeutralINR 2.26B-22.12―0.45%-27.77%-61.55%

* General Sector Average

Performance Comparison

0%50%100%150%IN:KANORICHEMIN:AMNPLSTIN:DEEPAKNTRIN:DIAMINESQIN:INDOAMININ:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:KANORICHEM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:KANORICHEMKanoria Chemicals & Industries Ltd168.9091.12117.15%
IN:AMNPLSTAmines & Plasticizers Ltd.143.00-70.91-33.15%
IN:DEEPAKNTRDeepak Nitrite Limited1519.50-208.95-12.09%
IN:DIAMINESQDiamines & Chemicals Ltd.224.35-45.25-16.78%
IN:INDOAMINIndo Amines Limited119.55-12.92-9.75%
IN:VALIANTORGValiant Organics Limited419.85114.8537.66%

Kanoria Chemicals & Industries Ltd Corporate Events

Kanoria Chemicals Publishes Unaudited Q1 FY2026 Results Across Public Channels

Aug 12, 2026

Kanoria Chemicals & Industries Ltd has announced that its Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 at a meeting held on 11 August 2026. The company subsequently pub...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 11, 2026